FDA Panel Approves Merck’s COVID Treatment Pill

NBC News reports:

A Food and Drug Administration advisory panel voted Tuesday to recommend Merck’s experimental antiviral pill to treat Covid-19 for emergency use authorization, paving the way for the agency to clear the first oral drug for the disease.

Members of the agency’s Antimicrobial Drugs Advisory Committee voted 13-10 in favor of the treatment, called molnupiravir, for use in adults with mild to moderate Covid-19 who are at risk for severe disease or hospitalization.

The FDA is not required to follow the advisory committee’s guidance, but it usually does. The nation is currently averaging 5,456 Covid hospitalizations and 1,032 deaths per day, according to the Centers for Disease Control and Prevention.

Read the full article.